Modality Options for End-Stage Renal Disease Care

Chronic Kidney Disease, Dialysis, & Transplantation

Volumn , Issue , 2005, Pages 279-306

  Nesrallah, Gihad E ^a   Blake, Peter G ^b   Mendelssohn, David C ^a,c  

^a HUMBER RIVER REGIONAL HOSPITAL   (Canada)

^b UNIVERSITY OF WESTERN ONTARIO   (Canada)

^c UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 77953286118     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-1-4160-0158-4.50019-7     Document Type: Chapter

References (220)

1. USRDS 2003 annual data report: Atlas of end-stage renal disease in the United States 2003, United States Renal Data System, National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, MD.
2. Canadian Organ Replacement Registry (CORR): 2001 annual report. Don Mills, Ontario, Canadian Institute for Health Information, 2001.
3. Kalo Z, Jaray J, Nagy J Economic evaluation of kidney transplantation versus hemodialysis in patients with end-stage renal disease in Hungary. Prog Transplant 2001, 11(3):188-193.
4. Winkelmayer WC, Weinstein MC, Mittleman MA, et al. Health economic evaluations: The special case of end-stage renal disease treatment. Med Decis Making 2002, 22(5):417-430.
5. Mowatt G, Vale L, Perez J, et al. Systematic review of the effectiveness and cost-effectiveness, and economic evaluation, of home versus hospital or satellite unit haemodialysis for people with end-stage renal failure. Health Technol Assess 2003, 7(2):1-174.
6. Lee H, Manns B, Taub K, et al. Cost analysis of ongoing care of patients with end-stage renal disease: The impact of dialysis modality and dialysis access. Am J Kidney Dis 2002, 40(3):611-622.
7. Blake PG, Finkelstein FO Why is the proportion of patients doing peritoneal dialysis declining in North America?. Perit Dial Int 2001, 21(2):107-114.
8. Mehta RL, Letteri JM Current status of renal replacement therapy for acute renal failure. A survey of U.S. nephrologists. The National Kidney Foundation Council on Dialysis. Am J Nephrol 1999, 19(3):377-382.
9. Hyman A, Mendelssohn DC Current Canadian approaches to dialysis for acute renal failure in the ICU. Am J Nephrol 2002, 22(1):29-34.
10. Merino JL, Rivera M, Teruel JL, et al. CAPD as treatment of chronic debilitating hemodialysis hypotension. Perit Dial Int 2002, 22(3):429.
11. Vande WJ, Raes A, Castillo D, et al. New perspectives for PD in acute renal failure related to new catheter techniques and introduction of APD. Adv Perit Dial 1997, 13:190-194.
12. Del Peso G, Bajo MA, Costero O, et al. Risk factors for abdominal wall complications in peritoneal dialysis patients. Perit Dial Int 2003, 23(3):249-254.
13. Piraino B Infectious complications of peritoneal dialysis. Perit Dial Int 1997, 17(suppl 3):S15-S18.
14. Graff J, Fugleberg S, Brahm J, Fogh-Andersen N Transperitoneal transport of sodium during hypertonic peritoneal dialysis. Clin Physiol 1996, 16(1):31-39.
15. Delarue J, Maingourd C Acute metabolic effects of dialysis fluids during CAPD. Am J Kidney Dis 2001, 37(1 suppl 2):S103-S107.
16. Burkart JM Effect of peritoneal dialysis prescription and peritoneal membrane transport characteristics on nutritional status. Perit Dial Int 1995, 15(5 suppl):S20-S35.
17. Pierratos A Daily hemodialysis: Why the renewed interest?. Am J Kidney Dis 1998, 32(6 suppl 4):S76-S82.
18. Kjellstrand C, Ting G Daily hemodialysis: Dialysis for the next century. Adv Ren Replace Ther 1998, 5(4):267-274.
19. Jassal SV, Krishna G, Mallick NP, Mendelssohn DC Attitudes of British Isles' nephrologists towards dialysis modality selection: A questionnaire study. Nephrol Dial Transplant 2002, 17(3):474-477.
20. Jung B, Blake PG, Mehta RL, Mendelssohn DC Attitudes of Canadian nephrologists toward dialysis modality selection. Perit Dial Int 1999, 19(3):263-268.
21. Mendelssohn DC, Mullaney SR, Jung B, et al. What do American nephologists think about dialysis modality selection?. Am J Kidney Dis 2001, 37(1):22-29.
22. Ting GO, Kjellstrand C, Freitas T, et al. Long-term study of high-comorbidity ESRD patients converted from conventional to short daily hemodialysis. Am J Kidney Dis 2003, 42(5):1020-1035.
23. Kjellstrand CM, Rosa AA, Shideman JR, et al. Optimal dialysis frequency and duration: The "unphysiology hypothesis.". Kidney Int Suppl 1978, 8:S120-S124.
24. Heidenheim AP, Muirhead N, Moist L, Lindsay RM Patient quality of life on quotidian hemodialysis. Am J Kidney Dis 2003, 42(1 suppl):36-41.
25. Nesrallah G, Suri R, Moist L, et al. Volume control and blood pressure management in patients undergoing quotidian hemodialysis. Am J Kidney Dis 2003, 42(1 suppl):13-17.
26. Pierratos A, Ouwendyk M, Francoeur R, et al. Nocturnal hemodialysis: Three-year experience. J Am Soc Nephrol 1998, 9(5):859-868.
27. Woods JD, Port FK, Orzol S, et al. Clinical and biochemical correlates of starting "daily" hemodialysis. Kidney Int 1999, 55(6):2467-2476.
28. Al Hejaili F, Kortas C, Leitch R, et al. Nocturnal but not short hours quotidian hemodialysis requires an elevated dialysate calcium concentration. J Am Soc Nephrol 2003, 14(9):2322-2328.
29. Lindsay RM, Alhejaili F, Nesrallah G, et al. Calcium and phosphate balance with quotidian hemodialysis. Am J Kidney Dis 2003, 42(1 suppl):24-29.
30. Suri R, Depner TA, Blake PG, et al. Adequacy of quotidian hemodialysis. Am J Kidney Dis 2003, 42(1 suppl):42-48.
31. McFarlane PA, Bayoumi AM, Pierratos A, Redelmeier DA The quality of life and cost utility of home nocturnal and conventional in-center hemodialysis. Kidney Int 2003, 64(3):1004-1011.
32. McFarlane PA, Pierratos A, Redelmeier DA Cost savings of home nocturnal versus conventional in-center hemodialysis. Kidney Int 2002, 62(6):2216-2222.
33. Kroeker A, Clark WF, Heidenheim AP, et al. An operating cost comparison between conventional and home quotidian hemodialysis. Am J Kidney Dis 2003, 42(1 suppl):49-55.
34. Kiberd BA Equitable allocation versus best outcome: Competing economic and ethical strategies in renal transplantation. Ann R Coll Physicians Surg Can 1992, 25(7):446-448.
35. Arend SM, Mallat MJ, Westendorp RJ, et al. Patient survival after renal transplantation: More than 25 years follow-up. Nephrol Dial Transplant 1997, 12(8):1672-1679.
36. Taube DH, Winder EA, Ogg CS, et al. Successful treatment of middle aged and elderly patients with end stage renal disease. Br Med J (Clin Res Ed) 1983, 286(6383):2018-2020.
37. Fauchald P, Albrechtsen D, Leivestad T, et al. Renal replacement therapy in elderly patients. Transpl Int 1988, 1(3):131-134.
38. Wolfe RA, Ashby VB, Milford EL, et al. Comparison of mortality in all patients on dialysis, patients on dialysis awaiting transplantation, and recipients of a first cadaveric transplant. N Engl J Med 1999, 341(23):1725-1730.
39. Snyder JJ, Kasiske BL, Gilbertson DT, Collins AJ A comparison of transplant outcomes in peritoneal and hemodialysis patients. Kidney Int 2002, 62(4):1423-1430.
40. Khan IH, Garratt AM, Kumar A, et al. Patients' perception of health on renal replacement therapy: Evaluation using a new instrument. Nephrol Dial Transplant 1995, 10(5):684-689.
41. Simmons RG, Abress L Quality-of-life issues for end-stage renal disease patients. Am J Kidney Dis 1990, 15(3):201-208.
42. Dew MA, Switzer GE, Goycoolea JM, et al. Does transplantation produce quality of life benefits? A quantitative analysis of the literature. Transplantation 1997, 64(9):1261-1273.
43. Vanrenterghem Y, Verberckmoes R Pre-emptive kidney transplantation. Nephrol Dial Transplant 1998, 13(10):2466-2468.
44. Mange KC, Joffe MM, Feldman HI Preemptive living donor kidney transplantation in the United States. J Am Soc Nephrol 1998, 9:686A.
45. Mange KC, Weir MR Preemptive renal transplantation: Why not?. Am J Transplant 2003, 3:1336-1340.
46. Katz SM, Kerman RH, Golden D, et al. Preemptive transplantation: An analysis of benefits and hazards in 85 cases. Transplantation 1991, 51(2):351-355.
47. Roake JA, Cahill AP, Gray CM, Gray DW, Morris PJ Preemptive cadaveric renal transplantation-clinical outcome. Transplantation 1996, 62(10):1411-1416.
48. Papalois VE, Moss A, Gillingham KJ, et al. Pre-emptive transplants for patients with renal failure: An argument against waiting until dialysis. Transplantation 2000, 70(4):625-631.
49. Wanner C, Zimmermann J, Quaschning T, Galle J Inflammation, dyslipidemia and vascular risk factors in hemodialysis patients. Kidney Int Suppl 1997, 62:S53-S55.
50. Gris JC, Branger B, Vecina F, et al. Increased cardiovascular risk factors and features of endothelial activation and dysfunction in dialyzed uremic patients. Kidney Int 1994, 46(3):807-813.
51. Lariviere R, Lebel M Endothelin-1 in chronic renal failure and hypertension. Can J Physiol Pharmacol 2003, 81(6):607-621.
52. Ohkuma T, Minagawa T, Takada N, et al. C-reactive protein, lipoprotein(a), homocysteine, and male sex contribute to carotid atherosclerosis in peritoneal dialysis patients. Am J Kidney Dis 2003, 42(2):355-361.
53. Chiarello PG, Vannucchi MT, Vannucchi H Hyperhomocysteinemia and oxidative stress during dialysis treatment. Ren Fail 2003, 25(2):203-213.
54. Mange KC, Joffe MM, Feldman HI Effect of the use or nonuse of long-term dialysis on the subsequent survival of renal transplants from living donors. N Engl J Med 2001, 344(10):726-731.
55. Kaul H, Girndt M, Sester U, et al. Initiation of hemodialysis treatment leads to improvement of T-cell activation in patients with end-stage renal disease. Am J Kidney Dis 2000, 35(4):611-616.
56. Descamps-Latscha B, Herbelin A, Nguyen AT, et al. Balance between IL-1 beta, TNF-alpha, and their specific inhibitors in chronic renal failure and maintenance dialysis. Relationships with activation markers of T cells, B cells, and monocytes. J Immunol 1995, 154(2):882-892.
57. Brenner BM, Milford EL Nephron underdosing: A programmed cause of chronic renal allograft failure. Am J Kidney Dis 1993, 21(5 suppl 2):66-72.
58. Asderakis A, Augustine T, Dyer P, et al. Pre-emptive kidney transplantation: The attractive alternative. Nephrol Dial Transplant 1998, 13(7):1799-1803.
59. Cosio FG, Alamir A, Yim S, et al. Patient survival after renal transplantation. I. The impact of dialysis pre-transplant. Kidney Int 1998, 53(3):767-772.
60. Meier-Kriesche HU, Port FK, Ojo AO, et al. Effect of waiting time on renal transplant outcome. Kidney Int 2000, 58(3):1311-1317.
61. Meier-Kriesche HU, Kaplan B Waiting time on dialysis as the strongest modifiable risk factor for renal transplant outcomes: A paired donor kidney analysis. Transplantation 2002, 74(10):1377-1381.
62. Alfani D, Pretagostini R, Bruzzone P, et al. Kidney transplantation from living unrelated donors. Clin Transpl 1998, 205-212.
63. Turenne MN, Port FK, Strawderman RL, et al. Growth rates in pediatric dialysis patients and renal transplant recipients. Am J Kidney Dis 1997, 30(2):193-203.
64. John AG, Rao M, Jacob CK Preemptive live-related renal transplantation. Transplantation 1998, 66(2):204-209.
65. Parfrey PS, Forbes RD, Hutchinson TA, et al. The clinical and pathological course of hepatitis B liver disease in renal transplant recipients. Transplantation 1984, 37(5):461-466.
66. Rao KV, Kasiske BL, Anderson WR Variability in the morphological spectrum and clinical outcome of chronic liver disease in hepatitis B-positive and B-negative renal transplant recipients. Transplantation 1991, 51(2):391-396.
67. Murthy BV, Pereira BJ A 1990s perspective of hepatitis C, human immunodeficiency virus, and tuberculosis infections in dialysis patients. Semin Nephrol 1997, 17(4):346-363.
68. Correa-Rotter R The cost barrier to renal replacement therapy and peritoneal dialysis in the developing world. Perit Dial Int 2001, 21(suppl 3):S314-S317.
69. Murphy SW, Foley RN, Barrett BJ, et al. Comparative hospitalization of hemodialysis and peritoneal dialysis patients in Canada. Kidney Int 2000, 57(6):2557-2563.
70. Harris SA, Lamping DL, Brown EA, Constantinovici N Clinical outcomes and quality of life in elderly patients on peritoneal dialysis versus hemodialysis. Perit Dial Int 2002, 22(4):463-470.
71. Korevaar JC, Feith GW, Dekker FW, et al. Effect of starting with hemodialysis compared with peritoneal dialysis in patients new on dialysis treatment: A randomized controlled trial. Kidney Int 2003, 64(6):2222-2228.
72. Maiorca R, Vonesh EF, Cavalli P, et al. A multicenter, selection-adjusted comparison of patient and technique survivals on CAPD and hemodialysis. Perit Dial Int 1991, 11(2):118-127.
73. Ganesh SK, Hulbert-Shearon T, Port FK, et al. Mortality differences by dialysis modality among incident ESRD patients with and without coronary artery disease. J Am Soc Nephrol 2003, 14(2):415-424.
74. Fenton SS, Schaubel DE, Desmeules M, et al. Hemodialysis versus peritoneal dialysis: A comparison of adjusted mortality rates. Am J Kidney Dis 1997, 30(3):334-342.
75. Collins AJ, Hao W, Xia H, et al. Mortality risks of peritoneal dialysis and hemodialysis. Am J Kidney Dis 1999, 34(6):1065-1074.
76. Murphy SW, Foley RN, Barrett BJ, et al. Comparative mortality of hemodialysis and peritoneal dialysis in Canada. Kidney Int 2000, 57(4):1720-1726.
77. Foley RN: Comparing the incomparable. In Hemodialysis vs. Peritoneal Dialysis in Observational Studies. Peritoneal Dialysis International, 2004 (in press).
78. Davies SJ Peritoneal dialysis solutions. Chronic Kidney Disease, Dialysis and Transplantation 2004, Elsevier, Burlington, MA. B.J.G. Pereira, M. Sayegh, P.G. Blake (Eds.).
79. Perez RA, Blake PG, Jindal KA, et al. Changes in peritoneal dialysis practices in Canada 1996-1999. Perit Dial Int 2003, 23(1):53-57.
80. Gokal R Newer peritoneal dialysis solutions. Adv Ren Replace Ther 2000, 7(4):302-309.
81. Guo A, Mujais S Patient and technique survival in peritoneal dialysis in the United States: Evaluation in large incident cohorts. Kidney Int 2003, 88:S3-S12.
82. Bloembergen WE, Port FK, Mauger EA, Wolfe RA A comparison of mortality between patients treated with hemodialysis and peritoneal dialysis. J Am Soc Nephrol 1995, 6(2):177-183.
83. Stack AG, Molony DA, Rahman NS, et al. Impact of dialysis modality on survival of new ESRD patients with congestive heart failure in the United States. Kidney Int 2003, 64(3):1071-1079.
84. Heaf JG, Lokkegaard H, Madsen M Initial survival advantage of peritoneal dialysis relative to haemodialysis. Nephrol Dial Transplant 2002, 17(1):112-117.
85. Locatelli F, Marcelli D, Conte F, et al. Survival and development of cardiovascular disease by modality of treatment in patients with end-stage renal disease. J Am Soc Nephrol 2001, 12(11):2411-2417.
86. Termorshuizen F, Korevaar JC, Dekker FW, et al. Hemodialysis and peritoneal dialysis: Comparison of adjusted mortality rates according to the duration of dialysis: Analysis of The Netherlands Cooperative Study on the Adequacy of Dialysis 2. J Am Soc Nephrol 2003, 14(11):2851-2860.
87. Vonesh EF, Moran J Mortality in end-stage renal disease: A reassessment of differences between patients treated with hemodialysis and peritoneal dialysis. J Am Soc Nephrol 1999, 10(2):354-365.
88. Schaubel DE, Morrison HI, Fenton SS Comparing mortality rates on CAPD/CCPD and hemodialysis. The Canadian experience: Fact or fiction?. Perit Dial Int 1998, 18(5):478-484.
89. Blake PG Trends in patient and technique survival in peritoneal dialysis and strategies: How are we doing and how can we do better?. Adv Ren Replace Ther 2000, 7(4):324-337.
90. Van Biesen W, Vanholder RC, Veys N, et al. An evaluation of an integrative care approach for end-stage renal disease patients. J Am Soc Nephrol 2000, 11(1):116-125.
91. Lai KN, Lo WK Optimal peritoneal dialysis for patients from Hong Kong. Perit Dial Int 1999, 19(suppl 3):S26-S31.
92. Blake PG Integrated end-stage renal disease care: The role of peritoneal dialysis. Nephrol Dial Transplant 2001, 16(suppl 5):61-66.
93. Longenecker JC, Coresh J, Klag MJ, et al. Validation of comorbid conditions on the end-stage renal disease medical evidence report: The CHOICE study. Choices for Healthy Outcomes in Caring for ESRD. J Am Soc Nephrol 2000, 11(3):520-529.
94. Schaubel DE, Blake PG, Fenton SS Trends in CAPD technique failure: Canada, 1981-1997. Perit Dial Int 2001, 21(4):365-371.
95. Schaubel DE, Fenton SS Trends in mortality on peritoneal dialysis: Canada, 1981-1997. J Am Soc Nephrol 2000, 11(1):126-133.
96. Sennfalt K, Magnusson M, Carlsson P Comparison of hemodialysis and peritoneal dialysis: A cost-utility analysis. Perit Dial Int 2002, 22(1):39-47.
97. Mendelssohn DC, Pierratos A Reformulating the integrated care concept for the new millennium. Perit Dial Int 2002, 22(1):5-8.
98. Thamer M, Hwang W, Fink NE, et al. U.S. nephrologists' recommendation of dialysis modality: Results of a national survey. Am J Kidney Dis 2000, 36(6):1155-1165.
99. Little J, Irwin A, Marshall T, et al. Predicting a patient's choice of dialysis modality: Experience in a United Kingdom renal department. Am J Kidney Dis 2001, 37(5):981-986.
100. Prichard SS Treatment modality selection in 150 consecutive patients starting ESRD therapy. Perit Dial Int 1996, 16:69-72.
101. Golper TA, Vonesh EF, Wolfson M, et al. The impact of pre-ESRD education on dialysis modality selection. J Am Soc Nephrol 2000, 11:231A.
102. Lameire N, Van Biesen W, Dombros N, et al. The referral pattern of patients with ESRD is a determinant in the choice of dialysis modality. Perit Dial Int 1997, 17(suppl 2):S161-S166.
103. The USRDS Morbidity and Mortality Study: Wave 2. Am J Kidney Dis 1998, 32:S67-S85. United States Renal Data System.
104. Mendelssohn DC CSN Professional and Public Policy Committee. Principles of end stage renal disease care. Annals RCPSC 1997, 30:271-273.
105. Miskulin DC, Meyer KB, Athienites NV, et al. Comorbidity and other factors associated with modality selection in incident dialysis patients: The CHOICE study. Choices for healthy outcomes in caring for end-stage renal disease. Am J Kidney Dis 2002, 39(2):324-336.
106. Stack AG Determinants of modality selection among incident U.S. dialysis patients: Results from a national study. J Am Soc Nephrol 2002, 13(5):1279-1287.
107. Baum M, Powell D, Calvin S, et al. Continuous ambulatory peritoneal dialysis in children: Comparison with hemodialysis. N Engl J Med 1982, 307(25):1537-1542.
108. Stefanidis CJ, Hewitt IK, Balfe JW Growth in children receiving continuous ambulatory peritoneal dialysis. J Pediatr 1983, 102(5):681-685.
109. Ledermann SE, Scanes ME, Fernando ON, et al. Long-term outcome of peritoneal dialysis in infants. J Pediatr 2000, 136(1):24-29.
110. Lerner GR, Warady BA, Sullivan EK, Alexander SR Chronic dialysis in children and adolescents. The 1996 annual report of the North American Pediatric Renal Transplant Cooperative Study. Pediatr Nephrol 1999, 13(5):404-417.
111. Shetty A, Oreopoulous DG Peritoneal dialysis: Its indications and contraindications. Dial Transplant 2000, 29:71-77.
112. Nissenson AR, Prichard SS, Cheng IKP Non-medical factors that impact on ESRD modality selection. Kidney Int 1993, 43(S40):S120-S127.
113. Nissenson AR, Prichard SS, Cheng IKP, et al. ESRD modality selection into the 21st century: The importance of non medical factors. ASAIO J 1997, 143-150.
114. Goeree R, Manalich J, Grootendorst P, et al. Cost analysis of dialysis treatments for end-stage renal disease (ESRD). Clin Invest Med 1995, 18(6):455-464.
115. Bruns FJ, Seddon P, Saul M, Zeidel ML The cost of caring for end-stage kidney disease patients: An analysis based on hospital financial transaction records. J Am Soc Nephrol 1998, 9(5):884-890.
116. Garella S The costs of dialysis in the USA. Nephrol Dial Transplant 1997, 12(suppl 1):10-21.
117. McFarlane PA, Mendelssohn DC A call to arms: Economic barriers to optimal dialysis care. Perit Dial Int 2000, 20(1):7-12.
118. Van Biesen W, Wiedemann M, Lameire N End-stage renal disease treatment: A European perspective. J Am Soc Nephrol 1998, 9(12 suppl):S55-S62.
119. Blake PG, Mendelssohn DC, Toffelmire EB New developments in hemodialysis delivery in Ontario, 1995-2000. Nephrol News Issues 2000, 14(11):72-80.
120. Mendelssohn D Instability in Canadian Medicare: The case of dialysis delivery. Nephrol News Issues 1996, 10(11):37-41.
121. Levin A Consequences of late referral on patient outcomes. Nephrol Dial Transplant 2000, 15(suppl 3):8-13.
122. Eadington DW Delayed referral for dialysis: Higher morbidity and higher costs. Semin Dial 1995, 8:258-260.
123. Hood SA, Sondheimer JH Impact of pre-ESRD management on dialysis outcomes: A review. Semin Dial 1998, 11(3):175-180.
124. Obrador GT, Pereira BJ Early referral to the nephrologist and timely initiation of renal replacement therapy: A paradigm shift in the management of patients with chronic renal failure. Am J Kidney Dis 1998, 31(3):398-417.
125. Obrador GT, Arora P, Kausz AT, Pereira BJ Pre-end stage renal disease care in the United States: A state of disrepair. J Am Soc Nephrol 1998, 12:S44-S54.
126. Ismail N, Neyra R, Hakim R The medical and economical advantages of early referral of chronic renal failure patients to renal specialists. Nephrol Dial Transplant 1998, 13(2):246-250.
127. Mendelssohn DC, Barrett BJ, Brownscombe LM, et al. Elevated levels of serum creatinine: Recommendations for management and referral. CMAJ 1999, 161(4):413-417.
128. Pereira BJ, Burkart JM, Parker TF Strategies for influencing outcomes in pre-ESRD and ESRD patients. Am J Kidney Dis 1998, 32(6 suppl 4):S2-S4.
129. Innes A, Rowe PA, Burden RP, Morgan AG Early deaths on renal replacement therapy: The need for early nephrological referral. Nephrol Dial Transplant 1992, 7:467-471.
130. Ratcliffe PJ, Phillips RE, Oliver DO Late referral for maintenance dialysis. Br Med J 1984, 288.
131. Sesso R, Belasco AG Late diagnosis of chronic renal failure and mortality on maintenance dialysis. Nephrol Dial Transplant 1996, 11(12):2417-2420.
132. Stack AG Impact of timing of nephrology referral and pre-ESRD care on mortality risk among new ESRD patients in the United States. Am J Kidney Dis 2003, 41(2):310-318.
133. Kinchen KS, Sadler J, Fink N, et al. The timing of specialist evaluation in chronic kidney disease and mortality. Ann Intern Med 2002, 137(6):479-486.
134. Avorn J, Bohn RL, Levy E, et al. Nephrologist care and mortality in patients with chronic renal insufficiency. Arch Intern Med 2002, 162(17):2002-2006.
135. Jungers P, Massy ZA, Nguyen-Khoa T, et al. Longer duration of predialysis nephrological care is associated with improved long-term survival of dialysis patients. Nephrol Dial Transplant 2001, 16(12):2357-2364.
136. Campbell JD, Ewigman B, Hosokawa M, Van Stone JC The timing of referral of patients with end stage renal disease. Dial Transplant 1989, 18:660-668.
137. Levin A, Lewis M, Mortiboy P, et al. Multidisciplinary predialysis programs: Quantification and limitations of their impact on patient outcomes in two Canadian settings. Am J Kidney Dis 1997, 29(4):533-540.
138. Arora P, Obrador GT, Ruthazer R, et al. Prevalence, predictors, and consequences of late nephrology referral at a tertiary care center. J Am Soc Nephrol 1999, 10(6):1281-1286.
139. Jungers P, Zingraff J, Page B, et al. Late referral to maintenance dialysis: Detrimental consequences. Nephrol Dial Transplant 1993, 8:1089-1093.
140. Avorn J, Winkelmayer WC, Bohn RL, et al. Delayed nephrologist referral and inadequate vascular access in patients with advanced chronic kidney failure. J Clin Epidemiol 2002, 55(7):711-716.
141. Rasgon S, Schwankovsky L, James-Rogers A, et al. An intervention for employment maintenance among blue-collar workers with end-stage renal disease. Am J Kidney Dis 1993, 22:403-412.
142. Schmidt RJ, Domico JR, Sorkin MI, Hobbs G Early referral and its impact on emergent first dialyses, health care costs, and outcome. Am J Kidney Dis 1998, 32(2):278-283.
143. Diaz-Buxo JA The importance of pre-ESRD education and early nephrological care in peritoneal dialysis selection and outcome. Perit Dial Int 1998, 18(4):363-365.
144. Wuerth DB, Finkelstein SH, Schwetz O, et al. Patients' descriptions of specific factors leading to modality selection of chronic peritoneal dialysis or hemodialysis. Perit Dial Int 2002, 22(2):184-190.
145. Gomez CG, Valido P, Celadilla O, et al. Validity of a standard information protocol provided to end-stage renal disease patients and its effect on treatment selection. Perit Dial Int 1999, 19(5):471-477.
146. Sesso R, Yoshihiro MM Time of diagnosis of chronic renal failure and assessment of quality of life in haemodialysis patients. Nephrol Dial Transplant 1997, 12(10):2111-2116.
147. Caskey FJ, Wordsworth S, Ben T, et al. Early referral and planned initiation of dialysis: What impact on quality of life?. Nephrol Dial Transplant 2003, 18(7):1330-1338.
148. Arora P, Kausz AT, Obrador GT, et al. Hospital utilization among chronic dialysis patients. J Am Soc Nephrol 2000, 11(4):740-746.
149. McLaughlin K, Manns B, Culleton B, et al. An economic evaluation of early versus late referral of patients with progressive renal insufficiency. Am J Kidney Dis 2001, 38(5):1122-1128.
150. Golper T Patient education: Can it maximize the success of therapy?. Nephrol Dial Transplant 2001, 16(suppl 7):20-24.
151. Charest AF, Mendelssohn DC Are North American nephrologists biased against peritoneal dialysis?. Perit Dial Int 2001, 21(4):335-337.
152. Hamburger R, Mattern W, Schreiber M, et al. A dialysis modality decision guide based on the experience of six dialysis centers. Dial Transplant 1990, 19:66-69.
153. Churchill DN An evidence-based approach to earlier initiation of dialysis. Am J Kidney Dis 1997, 30(6):899-906.
154. Nolph KD Rationale for early incremental dialysis with continuous ambulatory peritoneal dialysis. Nephrol Dial Transplant 1998, 13(suppl 6):117-119.
155. Mehrotra R, Nolph KD Argument for timely initiation of dialysis. J Am Soc Nephrol 1998, 9(12 suppl):S96-S99.
156. Bonomini V, Albertazzi A, Vangelista A, et al. Residual renal function and effective rehabilitation in chronic dialysis. Nephron 1976, 16(2):89-102.
157. Bonomini V, Feletti C, Scolari MP, Stefoni S Benefits of early initiation of dialysis. Kidney Int Suppl 1985, 17:S57-S59.
158. Update 2000. Am J Kidney Dis 2001, 37(1 suppl 1):S65-S136. II. NKF-K/DOQI Clinical Practice Guidelines for Peritoneal Dialysis Adequacy.
159. Churchill DN, Blake PG, Jindal KK, et al. Clinical practice guidelines for initiation of dialysis. Canadian Society of Nephrology. J Am Soc Nephrol 1999, 10(suppl 13):S289-S291.
160. Korevaar JC, Jansen MA, Dekker FW, et al. When to initiate dialysis: Effect of proposed U.S. guidelines on survival. Lancet 2001, 358(9287):1046-1050.
161. Roubicek C, Brunet P, Huiart L, et al. Timing of nephrology referral: Influence on mortality and morbidity. Am J Kidney Dis 2000, 36(1):35-41.
162. Ifudu O, Dawood M, Homel P, Friedman EA Timing of initiation of uremia therapy and survival in patients with progressive renal disease. Am J Nephrol 1998, 18(3):193-198.
163. Ellis PA, Reddy V, Bari N, Cairns HS Late referral of end-stage renal failure. QJM 1998, 91(11):727-732.
164. Fink JC, Burdick RA, Kurth SJ, et al. Significance of serum creatinine values in new end-stage renal disease patients. Am J Kidney Dis 1999, 34(4):694-701.
165. Beddhu S, Samore MH, Roberts MS, et al. Impact of timing of initiation of dialysis on mortality. J Am Soc Nephrol 2003, 14(9):2305-2312.
166. Traynor JP, Simpson K, Geddes CC, et al. Early initiation of dialysis fails to prolong survival in patients with end-stage renal failure. J Am Soc Nephrol 2002, 13(8):2125-2132.
167. Obrador GT, Arora P, Kausz AT, et al. Level of renal function at the initiation of dialysis in the U.S. end-stage renal disease population. Kidney Int 1999, 56(6):2227-2235.
168. Pifer TB, McCullough KP, Port FK, et al. Mortality risk in hemodialysis patients and changes in nutritional indicators: DOPPS. Kidney Int 2002, 62(6):2238-2245.
169. Lowrie EG, Lew NL Commonly measured laboratory variables in hemodialysis patients: Relationships among them and to death risk. Semin Nephrol 1992, 12(3):276-283.
170. Avram MM, Mittman N, Bonomini L, et al. Markers for survival in dialysis: A seven-year prospective study. Am J Kidney Dis 1995, 26(1):209-219.
171. Fleischmann E, Teal N, Dudley J, et al. Influence of excess weight on mortality and hospital stay in 1346 hemodialysis patients. Kidney Int 1999, 55(4):1560-1567.
172. van Olden RW, Krediet RT, Struijk DG, Arisz L Measurement of residual renal function in patients treated with continuous ambulatory peritoneal dialysis. J Am Soc Nephrol 1996, 7(5):745-750.
173. Bolton WK Renal physicians association clinical practice guideline: Appropriate patient preparation for renal replacement therapy: Guideline number 3. J Am Soc Nephrol 2003, 14(5):1406-1410.
174. Mendelssohn DC Reflections on the optimal dialysis modality distribution: A North American perspective. Nephrol News Issues 2002, 16(4):26-30.
175. Davies SJ, Van Biesen W, Nicholas J, Lameire N Integrated care. Perit Dial Int 2001, 21(suppl 3):S269-S274.
176. Ahlmen J, Carlsson L, Schonborg C Well-informed patients with end-stage renal disease prefer peritoneal dialysis to hemodialysis. Perit Dial Int 1993, 13(suppl 2):S196-S198.
177. Julius M, Kneisley JD, Carpentier-Alting P, et al. A comparison of employment rates of patients treated with continuous ambulatory peritoneal dialysis vs in-center hemodialysis (Michigan End-Stage Renal Disease Study). Arch Intern Med 1989, 149(4):839-842.
178. Merkus MP, Jager KJ, Dekker FW, et al. Quality of life in patients on chronic dialysis: Self-assessment 3 months after the start of treatment. The Necosad Study Group. Am J Kidney Dis 1997, 29(4):584-592.
179. Ahmed S, Addicott C, Qureshi M, et al. Opinions of elderly people on treatment for end-stage renal disease. Gerontology 1999, 45(3):156-159.
180. Lindsay RM, Leitch R, Heidenheim AP, Kortas C The London daily/nocturnal hemodialysis study-study design, morbidity, and mortality results. Am J Kidney Dis 2003, 42(1 suppl):5-12.
181. Peeters P, Rublee D, Just PM, Joseph A Analysis and interpretation of cost data in dialysis: Review of Western European literature. Health Policy 2000, 54(3):209-227.
182. Garcia-Maldonado M, Williams C, Smith ZM Mental performance in CAPD. Adv Perit Dial 1991, 7:105-107.
183. Szabo E, Moody H, Hamilton T, et al. Choice of treatment improves quality of life. A study on patients undergoing dialysis. Arch Intern Med 1997, 157(12):1352-1356.
184. De Vecchi AF, Scalamogna A, Colombini M, et al. Well being in patients on CAPD and hemodialysis. Int J Artif Organs 1994, 17(9):473-477.
185. Spanner E, Suri R, Heidenheim AP, Lindsay RM The impact of quotidian hemodialysis on nutrition. Am J Kidney Dis 2003, 42(1 suppl):30-35.
186. Maiorca R, Sandrini S, Cancarini GC, et al. Integration of peritoneal dialysis and transplantation programs. Perit Dial Int 1997, 17(suppl 2):S170-S174.
187. Geddes CC, Woo YM, Jardine AG The impact of delayed graft function on the long-term outcome of renal transplantation. J Nephrol 2002, 15(1):17-21.
188. Cecka JM The UNOS Scientific Renal Transplant Registry. Clin Transpl 1999, 1-21.
189. Bleyer AJ, Burkart JM, Russell GB, Adams PL Dialysis modality and delayed graft function after cadaveric renal transplantation. J Am Soc Nephrol 1999, 10(1):154-159.
190. Rottembourg J Residual renal function and recovery of renal function in patients treated by CAPD. Kidney Int Suppl 1993, 40:S106-S110.
191. Page DE, House A Important cost differences of blood transfusions and erythropoietin between hemodialysis and peritoneal dialysis patients. Adv Perit Dial 1998, 14:87-89.
192. Pereira BJ, Levey AS Hepatitis C virus infection in dialysis and renal transplantation. Kidney Int 1997, 51(4):981-999.
193. Coles GA, Williams JD What is the place of peritoneal dialysis in the integrated treatment of renal failure?. Kidney Int 1998, 54(6):2234-2240.
194. Faller B, Lameire N Evolution of clinical parameters and peritoneal function in a cohort of CAPD patients followed over 7 years. Nephrol Dial Transplant 1994, 9(3):280-286.
195. Lysaght MJ, Vonesh EF, Gotch F, et al. The influence of dialysis treatment modality on the decline of remaining renal function. ASAIO Trans 1991, 37(4):598-604.
196. Association with clinical outcomes. Canada-USA (CANUSA) Peritoneal Dialysis Study Group. J Am Soc Nephrol 1996, 7(2):198-207. Adequacy of dialysis and nutrition in continuous peritoneal dialysis.
197. Termorshuizen F, Korevaar JC, Dekker FW, et al. The relative importance of residual renal function compared with peritoneal clearance for patient survival and quality of life: An analysis of the Netherlands cooperative study on the adequacy of dialysis (NECOSAD)-2. Am J Kidney Dis 2003, 41(6):1293-1302.
198. Paniagua R, Amato D, Vonesh E, et al. Effects of increased peritoneal clearances on mortality rates in peritoneal dialysis: ADEMEX, a prospective, randomized, controlled trial. J Am Soc Nephrol 2002, 13(5):1307-1320.
199. Lameire N, Vanholder RC, Van Loo A, et al. Cardiovascular diseases in peritoneal dialysis patients: The size of the problem. Kidney Int Suppl 1996, 56:S28-S36.
200. Stack AG, Saran R Clinical correlates and mortality impact of left ventricular hypertrophy among new ESRD patients in the United States. Am J Kidney Dis 2002, 40(6):1202-1210.
201. Wang AY, Wang M, Woo J, et al. A novel association between residual renal function and left ventricular hypertrophy in peritoneal dialysis patients. Kidney Int 2002, 62(2):639-647.
202. Konings CJ, Kooman JP, Schonck M, et al. Fluid status in CAPD patients is related to peritoneal transport and residual renal function: Evidence from a longitudinal study. Nephrol Dial Transplant 2003, 18(4):797-803.
203. Wang AY, Sea MM, Ip R, et al. Independent effects of residual renal function and dialysis adequacy on dietary micronutrient intakes in patients receiving continuous ambulatory peritoneal dialysis. Am J Clin Nutr 2002, 76(3):569-576.
204. Randerson DH, Chapman GV, Farrell PC Amino acid and dietary status in CAPD patients. Peritoneal Dialysis 1981, 171-191. Churchill Livingstone, Edinborough. R.C. Atkins, P.C. Farrell, N. Thompson (Eds.).
205. Bergstrom J, Furst P, Alvestrand A, Lindholm B Protein and energy intake, nitrogen balance and nitrogen losses in patients treated with continuous ambulatory peritoneal dialysis. Kidney Int 1993, 44(5):1048-1057.
206. Montini G, Amici G, Milan S, et al. Middle molecule and small protein removal in children on peritoneal dialysis. Kidney Int 2002, 61(3):1153-1159.
207. Blake PG A critique of the Canada/USA (CANUSA) Peritoneal Dialysis Study. Perit Dial Int 1996, 16(3):243-245.
208. Anwar N, Bhatnagar D, Short CD, et al. Serum lipoprotein (a) concentrations in patients undergoing continuous ambulatory peritoneal dialysis. Nephrol Dial Transplant 1993, 8(1):71-74.
209. Kronenberg F, Lingenhel A, Neyer U, et al. Prevalence of dyslipidemic risk factors in hemodialysis and CAPD patients. Kidney Int Suppl 2003, 84:S113-S116.
210. Saldanha LF, Weiler EW, Gonick HC Effect of continuous ambulatory peritoneal dialysis on blood pressure control. Am J Kidney Dis 1993, 21(2):184-188.
211. Shinzato T, Nakai S, Akiba T, et al. Report of the annual statistical survey of the Japanese Society for Dialysis Therapy in 1996. Kidney Int 1999, 55(2):700-712.
212. Amann K, Mandelbaum A, Schwarz U, Ritz E Hypertension and left ventricular hypertrophy in the CAPD patient. Kidney Int Suppl 1996, 56:S37-S40.
213. Moustapha A, Gupta A, Robinson K, et al. Prevalence and determinants of hyperhomocysteinemia in hemodialysis and peritoneal dialysis. Kidney Int 1999, 55(4):1470-1475.
214. Chan CT, Floras JS, Miller JA, et al. Regression of left ventricular hypertrophy after conversion to nocturnal hemodialysis. Kidney Int 2002, 61(6):2235-2239.
215. Fagugli RM, Reboldi G, Quintaliani G, et al. Short daily hemodialysis: Blood pressure control and left ventricular mass reduction in hypertensive hemodialysis patients. Am J Kidney Dis 2001, 38(2):371-376.
216. Canziani ME, Cendoroglo NM, Saragoca MA, et al. Hemodialysis versus continuous ambulatory peritoneal dialysis: Effects on the heart. Artif Organs 1995, 19(3):241-244.
217. Bleyer AJ, Russell GB, Satko SG Sudden and cardiac death rates in hemodialysis patients. Kidney Int 1999, 55(4):1553-1559.
218. Ofsthun N, Labrecque J, Lacson E, et al. The effects of higher hemoglobin levels on mortality and hospitalization in hemodialysis patients. Kidney Int 2003, 63(5):1908-1914.
219. Marsh JT, Brown WS, Wolcott D, et al. RHuEPO treatment improves brain and cognitive function of anemic dialysis patients. Kidney Int 1991, 39(1):155-163.
220. Canadian Organ Replacement Registry. CORR EPREX Study 1998 Report. Toronto, Canadian Institute for Health Information, 1999; 220.